Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Amgen (NQ: AMGN )

280.07 +0.06 (+0.02%)
Streaming Delayed Price Updated: 4:00 PM EST, Nov 27, 2024 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Amgen

< Previous 1 2
...
6 7 8 9 10 11 12 13 14
...
47 48 Next >
Looking At Amgen's Recent Unusual Options Activity
Via Benzinga
Is Amgen Stock a Buy?
Amgen's stock isn't expensive, but the business does face some challenges, which could have investors thinking twice. 
Via The Motley Fool
Election Year Encore: Can 2020’s Top 7 Stock Winners Repeat Their Performance in 2024?
These seven companies were the top 2020 stocks. After their glory years have faded, they are looking to turn their fortunes around. 
Via InvestorPlace
3 High-Growth Biotech Stocks Investors Shouldn’t Sleep On in April
These high-growth biotech stocks are certainly worth considering for investors looking for market-beating returns in the long-term. 
Via InvestorPlace
The 3 Most Undervalued S&P 500 Stocks to Buy in April 2024
Our economy is on the up and up, and investing is a must. Let's review the most undervalued S&P 500 stocks to buy in April. 
Via InvestorPlace
Topics Economy Stocks
Exposures Economy US Equities
7 Analysts Have This To Say About Amgen
Via Benzinga
Amgen Unusual Options Activity For April 02
Via Benzinga
Amgen Options Trading: A Deep Dive into Market Sentiment
Via Benzinga
Is Amgen Stock a Buy Now?
There are some worrying signs. 
Via The Motley Fool
2 Biotech Stocks to Buy Hand Over Fist in April
These drugmakers have made important moves over the past year. 
Via The Motley Fool
3 Stocks to Consider Adding to Your Retirement Portfolio in April
Use the recent short-term weakness from these powerhouse companies' stocks to your advantage. 
Via The Motley Fool
Topics Retirement
Exposures Pension
Is Amgen The Rare Biotech With A Safe Dividend?
Amgen pays a $2.25 per share quarterly dividend, which comes out to a 3.3% yield. Biotech can be notoriously volatile, though, so can investors count on receiving the same dividend quarter after... 
Via Talk Markets
Biotech Sector Nears Breakout: Will it Outperform in Q2?
The Biotech sector ETF is consolidating in its upper range, indicating a potential sector breakout despite modest year-to-date gains 
Via MarketBeat
Topics ETFs
5 Healthcare Stocks to Buy for 2024
Healthcare stocks have been some of the top performers in 2024, and thanks to the potential of AI, these names will just keep heating up. 
Via InvestorPlace
Topics Artificial Intelligence
Exposures Artificial Intelligence
Looking At Amgen's Recent Unusual Options Activity
Via Benzinga
Redditors Identify 'Best Undervalued Stocks' For 2024
Savvy investors at Reddit discuss undervalued stocks for potential growth. Top picks include META, Google, Starbucks, Verizon, and others, with varied perspectives on their potential. 
Via Benzinga
Amgen's Diversified Portfolio To Drive Long-Term Growth, Though Uncertainties Loom, Analyst Says
Raymond James resumes coverage of Amgen highlighting its diversified portfolio and strong presence across therapeutic areas for sustainable long-term growth. Innovative pipeline in oncology, rare... 
Via Benzinga
7 Stocks That Will Drive the Weight Loss Drugs Market
The booming weight loss drug market presents both lucrative potential and significant risks for investors seeking to capitalize on the global obesity crisis. 
Via MarketBeat
3 Biotech Stocks to Buy on the Dip: March 2024
Some of the best opportunities can be found in dips in some of the top biotech stocks to buy. In fact, here are three. 
Via InvestorPlace
7 Dow Stocks to Buy on the Dip: March 2024
Analysts expect that the market may be heading toward a correction. These are seven of the best Dow stocks to buy when prices pull back. 
Via InvestorPlace
Topics Stocks
Exposures US Equities
Wall Street’s Favorite Biotech Stocks? 3 Names That Could Make You Filthy Rich
Some of the market’s favorite biotech stocks have created immense wealth, as evidenced with the recent weight-loss drug stock boom. 
Via InvestorPlace
Buffett’s Backdoor Buys: 3 Stocks His Secret Portfolio Is Quietly Accumulating
Warren Buffett stocks and Berkshire Hathaway's portfolio of companies are hidden investment vehicles hiding in plain sight. 
Via InvestorPlace
Hot Stocks: The 3 Best Opportunities for Investing in Biotech
Biotech stocks can offer some of the best risk vs. reward payoff in the stock market. These three are ones to buy now. 
Via InvestorPlace
Hot Stocks: The 3 Best Opportunities for Investing in the Dow
Although these Dow stocks are mature enterprises, they still have enough in the tank to pull off some surprises. 
Via InvestorPlace
Topics Stocks
Exposures US Equities
10 Health Care Stocks Whale Activity In Today's Session
Via Benzinga
4 Oversold Large Cap Stocks Yielding High Dividends
Overlooked, oversold large-cap stocks offer compelling dividend yields for investors seeking income and potential capital appreciation 
Via MarketBeat
Topics Artificial Intelligence Economy
Exposures Artificial Intelligence Interest Rates
Wall Street's Most Accurate Analysts' Views On 3 Health Care Stocks Delivering High-Dividend Yields
During times of turbulence and uncertainty in the markets, many investors turn to dividend-yielding stocks. These are often companies that have high free cash flows and reward shareholders with a high... 
Via Benzinga
The Dow’s Best Friends: 3 ‘Dogs’ Ready to Fetch Huge Returns
The Dogs of the Dow strategy is one of the best yearly strategies investors should use to make some good money. 
Via InvestorPlace
Topics Stocks
Exposures US Equities
Obesity Drugs 2024: The Skinny on the Top 3 Weight-Loss Stocks
With therapeutics focused on slimming down skyrocketing, it’s time to consider these top weight-loss stocks. 
Via InvestorPlace
The AI Race Gets Litigious
We've also got a look at the role of patents in pharmaceuticals and the "patent cliff" looming over the next decade. 
Via The Motley Fool
Topics Artificial Intelligence Intellectual Property
Exposures Artificial Intelligence Intellectual Property
< Previous 1 2
...
6 7 8 9 10 11 12 13 14
...
47 48 Next >
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.